Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

          
Total article views   Abstract views HTML views PDF downloads Totals
14,513 Dovepress* 11,191 443+ 2,109 11,634
PubMed Central* 20 2,859 728 2,879
Totals 11,211 3,302 2,837 14,513
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar